Investigating COVID-19 Severity Based on Serum Apelin-17 Levels and Inflammatory Mediators
Authors:
- Mitra Samareh FekriMFMitra Samareh Fekri
- Elham BarfzadeEBElham Barfzade
- Mehrdad FarokhniabMFMehrdad Farokhniab
- Seyed Mehdi Hashemi BajganiSBSeyed Mehdi Hashemi Bajgani
- Ahmad ShafahiASAhmad Shafahi
- Mohsen ShafiepourbMSMohsen Shafiepourb
- Sajjadeh MovahediniacSMSajjadeh Movahediniac
- Shariar DabiridSDShariar Dabirid
- Meysam YousefiMYMeysam Yousefi
- 1 February 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 18 (1) , 65-71
Abstract
Background: COVID-19 is an infectious disease caused by SARS-CoV-2 and can lead to acute respiratory distress. Objective: We aimed to investigate the association between COVID-19 severity and serum apelin-17 and inflammatory mediator levels. Method: This cross-sectional study was conducted on patients with COVID-19. COVID-19 infection was confirmed by the RT-PCR test. The patients' data were extracted from their records. Venous blood samples were obtained from the patients to investigate the serum levels of apelin-17 and inflammatory mediators. Results: Eighty-six COVID-19 patients were studied. The mean age of the participants was 55.56±14.88, and 43 (50%) were male. Clinical symptoms were dyspnea 77.6%, fever 52.3%, cough 48.8%, gastrointestinal symptoms 15.1%, and chest pain 7%. The overall mortality rate was 7%. No significant relationship was found between serum apelin-17 levels and COVID-19 severity (P= 0.48). However, there was a significant and direct relationship between COVID-19 severity and serum levels of CRP (P= 0.038) and D-dimer (P= 0.029). Conclusion: Serum apelin-17 levels were higher in recovered patients than those who died (4.90 vs. 3.19). Moreover, serum apelin-17 levels were higher in the patients admitted to the general ward than those admitted to the ICU (5.15 vs. 3.98). The difference was not statistically significant. However, there was a significant and direct relationship between serum apelin-17 levels and lymphocyte count (P= 0.022). Moreover, there was a significant and inverse relationship between lymphocyte count and COVID-19 severity (P= 0.004). Therefore, it can be interpreted that COVID-19 severity may decrease with an increase in serum apelin-17 levels. Therefore, to prove this hypothesis, a study with larger sample size is recommended.Keywords
This publication has 25 references indexed in Scilit:
- Developmental and hypoxia-induced cell death share common ultrastructural and biochemical apoptotic features in the central nervous systemNeuroscience, 2013
- Serum apelin-12 level is elevated in schoolchildren with atopic asthmaRespiratory Medicine, 2013
- Apelin Attenuates Hyperoxic Lung and Heart Injury in Neonatal RatsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Vascular Effects of Apelin In Vivo in ManJACC, 2008
- Emerging roles of apelin in biology and medicinePharmacology & Therapeutics, 2005
- Apelin signalling: a promising pathway from cloning to pharmacologyCellular Signalling, 2005
- Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cellsRegulatory Peptides, 2005
- Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cellsRegulatory Peptides, 2004
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998